Regenxbio Q2 2025 Earnings Preview

2 hours ago 1

Regenxbio (NASDAQ:RGNX) is scheduled to announce Q2 earnings results on Thursday, August 7th, before market open.
The consensus EPS Estimate is -$1.05 and the consensus Revenue Estimate is $40.87M (+83.3% Y/Y).
Over the last 3 months, EPS estimates have seen 2 upward revisions and 2 downward. Revenue estimates have seen 4 upward revisions and 2 downward.

Recommended For You